VANCOUVER, British Columbia, April 29, 2019 (FSCwire) : Viridium Pacific Group Ltd. (“Viridium” or the “Company”) (TSXV: VIR) (OTC: VIRFF) is pleased to provide shareholders with the Q1 financials and a corporate update. Financials Viridium has now filed its Q1 2019 consolidated interim financial statements, and management discussion...

VANCOUVER, British Columbia, April 18, 2019 (FSCwire) Viridium Pacific Group Ltd. (“Viridium” or the “Company”) (TSXV: VIR) (US OTC; VIRFF) is pleased to announce that the Company will host a conference call on Thursday May 2, 2019 at 1:15PM PST / 4:15PM EST to provide a...

VANCOUVER, British Columbia, April 15, 2019 (FSCwire) Viridium Pacific Group Ltd. (“Viridium” or the “Company”) (TSXV: VIR) (US OTC; VIRFF) is pleased to announce the engagement of Judy-Ann Pottinger of Vancouver, British Columbia, to provide comprehensive investor relations, corporate communications and investor outreach services.  Ms. Pottinger will develop and...

April 1, 2019,: Viridium Pacific Group Ltd. (“Viridium” or the “Company”) (TSXV: VIR) (OTCPink: VIRFF) is pleased to announce its wholly owned subsidiary, Experion Biotechnologies Inc. (“Experion”), a licensed cultivation and processor under the Cannabis Act, has completed its first shipment of Adult-Use cannabis to...

March 26, 2019: The Board of Directors of Viridium Pacific Group Ltd. (“Viridium” or the “Company”) (TSXV: VIR) (OTCPink: VIRFF) is pleased to announce the appointment of Ms. Kamini Hitkari to the position of Chief Financial Officer, commencing on March 26, 2019. Ms. Hitkari joins Viridium...

March 18, 2019: Viridium Pacific Group Ltd. (“Viridium” or the “Company”) (TSXV: VIR) (OTCPink: VIRFF) is pleased to provide shareholders with the year end financials and a corporate update. Year End Viridium has now filed the year end consolidated financial statements and management discussion and analysis for...

March 7, 2019: Viridium Pacific Group Ltd. (“Viridium” or the “Company”) (TSXV: VIR) (OTCPink: VIRFF) is pleased to announce its wholly owned subsidiary, Experion Biotechnologies Inc. (“Experion”), a licensed cultivation and processor under the Cannabis Act, has commenced clone sales as starting materials.  Its first...

LET’S CONFIRM YOU’RE AT LEGAL AGE TO ENTER OUR SITE.

You must be of legal age in accordance with the law of your province to access this website and/or to purchase cannabis. By entering this site you agree to our terms and conditions and privacy policy.